The review demonstrated that the WHO-5 has high clinimetric validity , can be used as an outcome measure balancing the wanted and unwanted effects of treatments , is a sensitive and specific screening tool for depression and its applicability across study fields is very high .
Conclusions : The WHO-5 is a short question naire consisting of 5 simple and non-invasive questions , which tap into the subjective well-being of the respondents .
The scale has adequate validity both as a screening tool for depression and as an outcome measure in clinical trials and has been applied successfully across a wide range of study fields
Background : The 5-item World Health Organization Well-Being Index ( WHO-5 ) is among the most widely used question naires assessing subjective psychological well-being .
Since its first publication in 1998 , the WHO-5 has been translated into more than 30 language s and has been used in research studies all over the world .
We now provide a systematic review of the literature on the WHO-5 .
Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting.
AIMS To investigate whether , in the treatment with chlordiazepoxide for outpatient alcohol withdrawal , there are advantages of symptom-triggered self-medication over a fixed-schedule regimen . METHODS A r and omized controlled trial in outpatient clinics for people suffering from alcohol dependence ( AD ) and alcohol-related problems ; 165 adult patients in an outpatient setting in a specialized alcohol treatment unit were r and omized 1:1 to either a symptom-triggered self-medication or tapered dose , using chlordiazepoxide .  Alcohol withdrawal symptoms , amount of medication , duration of symptoms , time to relapse and patient satisfaction were measured . Patients assessed their symptoms using the  Short Alcohol Withdrawal Scale ( SAWS ) . Patient satisfaction was monitored by the Diabetes Treatment Satisfaction Question naire . We used the Well-Being Index and the European addiction severity index for the 1-year follow-up . RESULTS We found no differences in the quantity of medication consumed , time to relapse , well being or treatment satisfaction . CONCLUSION Symptom-triggered self-medication was as safe as fixed-schedule medication in treating out patients with AD and mild to moderate symptoms of AWS . The SAWS is a powerful monitoring tool , because it is brief and permits the subject to log the withdrawal symptoms
The review demonstrated that the WHO-5 has high clinimetric validity , can be used as an outcome measure balancing the wanted and unwanted effects of treatments , is a sensitive and specific screening tool for depression and its applicability across study fields is very high .
Conclusions : The WHO-5 is a short question naire consisting of 5 simple and non-invasive questions , which tap into the subjective well-being of the respondents .
The scale has adequate validity both as a screening tool for depression and as an outcome measure in clinical trials and has been applied successfully across a wide range of study fields
Background : The 5-item World Health Organization Well-Being Index ( WHO-5 ) is among the most widely used question naires assessing subjective psychological well-being .
Since its first publication in 1998 , the WHO-5 has been translated into more than 30 language s and has been used in research studies all over the world .
We now provide a systematic review of the literature on the WHO-5 .